ArticleNPJ precision oncology2024
Understanding tumour growth variability in breast cancer xenograft models identifies PARP inhibition resistance biomarkers.
D Voulgarelis et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it